載入...
Lorlatinib in ALK- and ROS1-positive NSCLC: the future has a start
Na minha lista:
| 發表在: | Transl Lung Cancer Res |
|---|---|
| Main Authors: | , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
AME Publishing Company
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5943229/ https://ncbi.nlm.nih.gov/pubmed/29782561 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2018.02.04 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|